Target intelligence / Profile preview

Sacral nerves (S1-S5)

Target
S1-S5
Molecular classification
Other
01

Overview

The sacral nerves are a set of five pairs of spinal nerves (S1-S5) that emerge from the sacral region of the vertebral column and form part of the sacral plexus (StatPearls, 2023). They provide critical motor and sensory innervation to the lower extremities, the perineum, and the pelvic viscera, including the bladder and rectum (NIH, 2024). While the nerves themselves are anatomical structures rather than individual molecular targets, they are the site of action for sacral neuromodulation (SNM), a specialized therapy used to treat refractory overactive bladder and fecal incontinence (Mayo Clinic, 2023). In pharmacological contexts, sacral nerves are common sites for regional anesthesia where local anesthetics like lidocaine are applied to block voltage-gated sodium channels, thereby preventing pain transmission (Wikipedia, 2024). Because this entry represents a complex anatomical bundle of neurons and connective tissue rather than a specific protein or receptor, it is generally classified as an anatomical target rather than a molecular therapeutic target (Cleveland Clinic, 2023).

Other names
Sacral spinal nervesSacral nerve rootsNervi sacralesSacral plexus nerves
02

Mechanism of action

Local anesthetics inhibit voltage-gated sodium channels on the axons of the sacral nerves to block signal conduction; therapeutic neuromodulation uses electrical stimulation to modify nerve activity.

03

Biological functions

Motor innervation of the lower limbsSensory innervation of the pelvic regionParasympathetic control of the bladderRegulation of bowel functionSexual function mediation
04

Disease associations

Overactive bladderFecal incontinenceUrinary retentionChronic pelvic painCauda equina syndromePudendal neuralgia
05

Safety considerations

Nerve injuryParesthesiaLead migration (in neuromodulation)Infection at the site of implantable pulse generatorsPotential for permanent neurological deficit if compressed
06

Interacting drugs

Lidocaine

2 more in the full profile.

Beyond the preview

Go deeper on Sacral nerves (S1-S5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sacral nerves (S1-S5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call